文献速递脊柱外科

针状表面形貌双相磷酸钙陶瓷与自体骨在器械辅助后外侧脊柱融合中的疗效比较

Efficacy of Biphasic Calcium Phosphate Ceramic With a Needle-Shaped Surface Topography Versus Autograft in Instrumented Posterolateral Spinal Fusion.
PubMed 文献 · Spine (Phila Pa 1976) · 2024-06-17

这项多中心随机对照非劣效性试验在5个中心纳入100例需行1至6节段器械辅助后外侧融合的成人,患者自身左右侧对照,一侧植入10 cc BCP<μm颗粒,对侧植入10 cc自体骨。1年随访CT显示BCP<μm侧融合率为79%,自体骨侧为47%,配对比例绝对差为39.6%(95%CI 26.8-51.2;p<0.001),证实BCP<μm非劣效并提示优效。

要点

  • BCP<μm侧融合率79%,自体骨侧47%,差32个百分点(95%CI 23-41)。
  • 主要终点配对比例绝对差39.6%(95%CI 26.8-51.2;p<0.001),证实非劣效。
  • 作者认为BCP<μm作为单独陶瓷材料非劣效并提示优效,挑战自体骨最优的传统观念。

核心结论

  • 该临床试验证实MagnetOs颗粒作为单独陶瓷材料在后外侧脊柱融合中相对自体骨为非劣效,并提示优效。
  • 作者认为这些结果挑战了自体骨是最佳植骨材料的观念。

研究设计与样本

  • 多中心随机对照非劣效性试验,采用患者内自身左右侧对照设计。
  • 在5个参与中心纳入需行1至6节段器械辅助后外侧融合的成人。
  • 双侧器械安装与融合床准备后揭晓随机分配侧(左或右),每节段一侧放置10 cc BCP<μm颗粒(1至2 mm),对侧放置10 cc自体骨。
  • 以1年随访CT扫描系统评分融合,研究效能设定为检测配对二项比较中每治疗侧融合评分>15%的非劣效界值。

主要发现

  • 100例患者(57±12.9岁,62%女性)中,分析91例受试者和128个节段。
  • 每节段总体后外侧融合率(左侧和/或右侧)为83%。
  • 仅BCP<μm侧融合率为79%,自体骨侧为47%,差32个百分点(95%CI 23-41)。
  • 主要终点分析显示BCP<μm非劣效,配对比例绝对差为39.6%(95%CI 26.8-51.2;p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: A multicenter randomized controlled noninferiority trial with intrapatient comparisons. OBJECTIVE: The aim of this study was to determine noninferiority of a slowly resorbable biphasic calcium phosphate with submicron microporosity (BCP<μm, MagnetOs Granules) as an alternative for autograft in instrumented posterolateral fusion (PLF). SUMMARY OF BACKGROUND DATA: Successful spinal fusion with a solid bone bridge between the vertebrae is traditionally achieved by grafting with autologous iliac bone. However, the disadvantages of autografts and unsatisfactory fusion rates have prompted the exploration of alternatives, including ceramics. Nevertheless, clinical evidence for the standalone use of these materials is limited. METHODS: Adults indicated for instrumented PLF (1 to 6 levels) were enrolled at 5 participating centers. After bilateral instrumentation and fusion-bed preparation, the randomized allocation side (left or right) was disclosed. Per segment 10 cc of BCP<μm granules (1 to 2 mm) were placed in the posterolateral gutter on one side and 10 cc autograft on the contralateral side. Fusion was systematically scored on 1-year follow-up CT scans. The study was powered to detect >15% inferiority with binomial paired comparisons of the fusion performance score per treatment side. RESULTS: Of the 100 patients (57 ± 12.9 y, 62% female), 91 subjects and 128 segments were analyzed. The overall posterolateral fusion rate per segment (left and/or right) was 83%. For the BCP<μm side only the fusion rate was 79% versus 47% for the autograft side (difference of 32 percentage points, 95% CI, 23-41). Analysis of the primary outcome confirmed the noninferiority of BCP<μm with an absolute difference in paired proportions of 39.6% (95% CI, 26.8-51.2; p < 0.001). CONCLUSION: This clinical trial demonstrates noninferiority and indicates superiority of MagnetOs Granules as a standalone ceramic when compared to autograft for posterolateral spinal fusion. These results challange the belief that autologous bone is the most optimal graft material.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Stempels HW, Lehr AM, Delawi D, et al. Efficacy of Biphasic Calcium Phosphate Ceramic With a Needle-Shaped Surface Topography Versus Autograft in Instrumented Posterolateral Spinal Fusion. Spine (Phila Pa 1976). 2024. PMID: 38881258. doi:10.1097/BRS.0000000000005075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。